Cargando…
Bilateral multifocal central serous retinopathy following mRNA COVID-19 vaccine
We present a case of acute bilateral multifocal CSCR in a young healthy Caucasian female occurring 3 days after receiving the first dose of the Pfizer-BioNTech BNT162b2 COVID-19 mRNA vaccine. The true incidence of this adverse reaction might be underreported in asymptomatic unilateral or paracentral...
Autores principales: | Mechleb, N., Khoueir, Z., Assi, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046098/ https://www.ncbi.nlm.nih.gov/pubmed/35599048 http://dx.doi.org/10.1016/j.jfo.2022.02.001 |
Ejemplares similares
-
Alcoholic liver disease and bilateral multifocal central serous retinopathy: a case report
por: Gkotsi, Despoina, et al.
Publicado: (2013) -
Acute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccine
por: Fowler, Nicholas, et al.
Publicado: (2021) -
Central serous chorioretinopathy following the BNT162b2 mRNA vaccine
por: Hanhart, J., et al.
Publicado: (2022) -
Multifocal serous retinopathy with pemigatinib therapy for metastatic colon adenocarcinoma
por: Alekseev, Oleg, et al.
Publicado: (2021) -
Bilateral Multifocal Central Serous-Like Chorioretinopathy due to MEK Inhibition for Metastatic Cutaneous Melanoma
por: Schoenberger, Scott D., et al.
Publicado: (2013)